In April, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention both updated their recommendations for COVID vaccines, providing more flexibility for higher-risk individuals who want additional protection from the SARS-CoV-2 virus that causes COVID-19. The bivalent vaccines may not stand up very well against these new strains, which are evolving so fast that some …
Pfizer Inc. and its German vaccine partner BioNTech said their new COVID-19 booster designed to target the dominant Omicron subvariant produced more antibodies against the intended strains than did the original version of the shot. Pfizer and BioNTech plan to release additional data on the COVID-19 shots in the coming weeks to measure immune responses one month after administration of …
